As used in Chapter 4731-11 of the Administrative Code:
(A) "Controlled substance" means a drug, compound, mixture, preparation, or substance included in schedule I, II, III, IV, or V pursuant to the provisions of Chapter 3719. of the Revised Code.
(B) "Controlled substance stimulant" means any drug, compound, mixture, preparation, or substance which is classified as a stimulant in controlled substance schedule II, III, or IV listed in section 3719.41 of the Revised Code, or which is classified as a stimulant in controlled substances schedule II, III, or IV pursuant to section 3719.43 or 3719.44 of the Revised Code.
(C) "Utilize a controlled substance or controlled substance stimulant" means to prescribe, administer, dispense, supply, sell or give a controlled substance or controlled substance stimulant.
(D) "Recognized contraindication" means any contraindication to the use of a drug which is listed in the United States food and drug administration (hereinafter, "F.D.A.") approved labeling for the drug, or which the board determines to be accepted as a contraindication.
(E) "The board" means the state medical board of Ohio.
(F) "BMI" means body mass index, calculated as a person's weight in kilograms divided by height in meters squared.
(G) "Physician" means an individual holding a certificate under Chapter 4731. of the Revised Code to practice medicine and surgery, osteopathic medicine and surgery, or podiatric medicine and surgery and practicing within his or her scope of practice as defined by section 4731.51 of the Revised Code.
(H) "Board certified addictionologist or addiction psychiatrist" means a medical doctor or doctor of osteopathic medicine and surgery who holds one of the following certifications:
(1) Subspecialty board certification in addiction psychiatry from the American board of psychiatry and neurology;
(2) Board certification in addiction medicine from the American board of addiction medicine;
(3) Certification from the American society of addiction medicine; or
(4) Board certification with additional qualification in addiction medicine from the American osteopathic association.
(I) "Office based opioid treatment", or "OBOT", means treatment of opioid addiction utilizing a schedule III, IV or V controlled substance narcotic.
(J) "Opioid treatment program", or "OTP", sometimes referred to as a "methadone clinic", means a program licensed by the state to administer or dispense schedule II controlled substance narcotics in the maintenance or detoxification treatment of opioid addiction.
Five Year Review (FYR) Dates: 10/20/2014 and 01/31/2020
Promulgated Under: 119.03
Statutory Authority: 4731.05
Rule Amplifies: 47431.22
Prior Effective Dates: 11/17/86, 10/31/98, 9/1/00